About Stephen Snowdy
Stephen Snowdy is an executive officer, director and promoter at MultiValent Biotherapies.
Form D filings also name Stephen Snowdy as CEO and director at Calosyn Pharma.
Stephen Snowdy first appears on SEC filings in 2009.
Experience
This experience comes from Stephen Snowdy's profile and from SEC filings. For roles taken from filings, the years are when the filings name Stephen Snowdy in the role, so the role may have started earlier or lasted longer.
MultiValent Biotherapies, Inc. Current
Executive officer
Chief Executive Officer and Board Director (2025 – Present)
2025 – Present · Los Altos, CA
Develops targeted drug therapies for people with cancer.
OL
Oncotrope LLC Current
Owner
2025 – Present
AC
Ansley Venture Consulting Current
Owner
2010 – Present
LC
LadRx Corporation
Chief Executive Officer
2022 – 2025
VI
Visioneering Technologies Inc.
Chief Executive Officer
2008 – 2022
GT
Georgia Institute of Technology
Provost's Search Advisory Group for Dean of Engineering Search
2017
AL
Abby Med, LLC
Chief Executive Officer
2013 – 2016
WF
Wallace H. Coulter Foundation
Client Manager
2010 – 2016
MP
MB Venture Partners
Partner
2003 – 2011
UN
US Navy
Navy Diver / Submarine Warfare
1987 – 1992
Key Colleagues at Startups
The people Stephen Snowdy works with at each company, as listed on that company's latest Form D.
MultiValent Biotherapies, Inc. · Form D, Mar 2, 2026
FS
Fred Schwarzer
Executive officer, director and promoter
BK
Bruce Keyt
Executive officer, director and promoter
DS
Deborah Schwarzer
Chief Legal Officer and director
Calosyn Pharma, Inc. · Form D, Feb 29, 2012